Access the Recording
BDO USA, LLP invites you and your colleagues to a webinar on how changes in healthcare reimbursement are reshaping the healthcare landscape for biotechnology companies.
This webinar will:
Who should attend?
- Explain the impact of recent changes in reimbursement and how health systems are adopting new business models regarding pricing profitability
- Introduce the concept of value-based delivery for drugs
- Explain how improved outcomes and lower administration costs create more value
CEOs, CFOs, Chief Clinical Officers, Chief Medical Officers, or anyone else responsible for new biotechnology discoveries or administering drug therapies in the community